Potential Drug Interactions in Psychiatric Patients Undergoing Pangenotypic Therapy for Hepatitis C Virus Infection. [PDF]
Pharmaceuticals (Basel)Dybowska D, Pawłowska M, Kozielewicz D.
europepmc +1 more source
New drug: Sofosbuvir with velpatasvir for hepatitis C [PDF]
Australian Prescriber, 2017 openaire +2 more sources
Repurposing antiviral drugs targeting RNA viruses: A focus on the fusion protein of human metapneumovirus. [PDF]
North Clin IstanbAras M, Yayintas OT.
europepmc +1 more source
Direct-Acting Antivirals in Patients with Comorbidities for the Simplified Management of HCV Infection: An Expert Review with a Focus on Sofosbuvir-Velpatasvir. [PDF]
VirusesAghemo A +6 more
europepmc +1 more source
Histopathological features and eight-week split-tablet sofosbuvir/velpatasvir treatment in young children with acute hepatitis C: a case-series study. [PDF]
BMC Infect DisPan YJ, Chen RY, Ai YQ, Zeng QL.
europepmc +1 more source
Real-World Experience of Hepatitis C Treatment With Glecaprevir-Pibrentasvir During Pregnancy. [PDF]
Clin Infect DisMcCrary LM +9 more
europepmc +1 more source
An in-hospital referral program for hepatitis C virus elimination in patients with type 2 diabetes mellitus. [PDF]
J Chin Med AssocChi CT +8 more
europepmc +1 more source
Identification of Candidate Inhibitors to SARS-CoV-2's Enzymes and Potential Disruptors of Its Structural Proteins' Interactions. [PDF]
Adv Biomed ResMohammadian A +4 more
europepmc +1 more source
Recanalization of the Paraumbilical Vein Mimicking an Umbilical Hernia: A Case Report. [PDF]
CureusCavalcanti GA +3 more
europepmc +1 more source
Real-world efficacy and safety of sofosbuvir/velpatasvir/voxilaprevir in treatment-naive and treatment-experienced chronic hepatitis c patients: a single-center study. [PDF]
BMC GastroenterolTahmaz A, Üser Ü, Keçe MS.
europepmc +1 more source